Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Helicobacter pylori cell envelope is a complex, multi-layered barrier essential for the bacterium's survival and pathogenesis within the human gastric environment. It consists of an inner cytoplasmic membrane, a periplasmic space containing a peptidoglycan layer, and an outer membrane characterized by unique lipopolysaccharides (LPS) and a diverse array of outer membrane proteins (OMPs) (NCBI, 2021). These components facilitate critical biological processes, including acid resistance, nutrient acquisition, and high-affinity adhesion to gastric epithelial cells via proteins like BabA and SabA (UniProt, 2024). The envelope also plays a significant role in immune evasion through the expression of Lewis antigens on the LPS, which mimic host glycoconjugates (PubMed, 2022). Clinically, the cell envelope is a major target for eradication therapies; for instance, amoxicillin targets the peptidoglycan synthesis machinery, while bismuth salts cause direct structural damage to the membrane (StatPearls, 2023). Furthermore, the outer membrane serves as a scaffold for the Type IV secretion system, which injects virulence factors like CagA into host cells. Understanding the envelope's composition is critical for overcoming antibiotic resistance and developing novel vaccines or anti-adhesion therapies. However, the emergence of resistance through mutations in penicillin-binding proteins and changes in membrane permeability remains a significant therapeutic challenge.
The primary mechanism of action for drugs targeting the H. pylori cell envelope involves the inhibition of peptidoglycan cross-linking by binding to penicillin-binding proteins (PBPs), which results in cell wall instability and osmotic lysis (StatPearls, 2023). Additionally, bismuth-based agents provide a multi-targeted approach by directly disrupting the bacterial cell wall and cytoplasmic membrane, leading to the leakage of intracellular contents and bacterial death (NCBI, 2021).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori cell envelope and membrane components (H. pylori cell envelope).